View in EDS HTML Full Text PDF Full Text

Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan.

Saved in:
Bibliographic Details
Title: Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan.
Authors: Shen, Ming‐Ching1,2 (AUTHOR), Chou, Sheng‐Chieh2 (AUTHOR), Chiou, Shyh‐Shin3,4 (AUTHOR), Lin, Pei‐Chin3,4 (AUTHOR), Chen, Yeu‐Chin5,6 (AUTHOR), Lin, Hsuan‐Yu1 (AUTHOR), Lee, Yang‐Cheng7 (AUTHOR), Huang, Cih‐En8 (AUTHOR), Weng, Te‐Fu9 (AUTHOR), Huang, Ting‐Huan10 (AUTHOR), Chung, Chih‐Yuan11 (AUTHOR), Chen, Jiann‐Shiuh12 (AUTHOR), Chen, Shu‐Huey13,14 (AUTHOR), Cheng, Shin‐Nan15,16 (AUTHOR), Hsiao, Chih‐Cheng17 (AUTHOR), Huang, Yen‐Min18 (AUTHOR), Chen, Shih‐Hsiang19 (AUTHOR), Yu, Yuan‐Bin20 (AUTHOR), Lin, Shih‐Chiang20 (AUTHOR), Lin, Ching‐Yeh1 (AUTHOR)
Source: Haemophilia. Nov2023, Vol. 29 Issue 6, p1499-1508. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13518216
DOI:10.1111/hae.14880